The human monocytic cell line THP-1 was used as a model to study the mechanism of infection in the monocyte/macrophage, a natural target of lymphocytic choriomeningitis virus (LCMV) infection in vivo. Both the virulent strain, LCMV. WE, and the avirulent strain, LCMV. ARM, infected THP-1 cells, but did not stimulate THP-1 cells to secrete interleukin 1 (IL-1) or tumour necrosis factor (TNF-~). When lipopolysaccharide (LPS) was added to THP-1 cells together with LCMV, an 80 to 90 % reduction in the number of infected cells (measured by immunofluorescence) and a 90 % reduction in viral plaques was observed 5 to 6 days postinfection. Neither interferon ~t (IFN-~) nor IFN-fl were detected in supernatants from THP-1 cells after the addition of LCMV, LPS, or LPS plus LCMV. In contrast, the same levels of IL-1 and TNF-~ were observed in the presence of LPS and LCMV, or LPS alone. However, antibodies to IL-1, TNF-ct, intedeukin 6 and IFN-~ did not block the antiviral effect of LPS. In kinetic studies, LPS added 1 day after adding LCMV to THP-1 ceils was still effective in reducing the number of infected cells. Our findings suggest that LPS alters cellular metabolism, possibly through the induction of IFN-~, and that IFN-~ in the absence of LPS suppresses virus production.
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Mononuclear phagocytes play an important role in the regulation of the immune response (Rosenthal, 1980) . They serve many functions, including the maintenance of homeostasis and host defence against infection. Monocytes/macrophages also serve as targets and reservoirs for virus. Many viruses infect monocytes, for example cytomegalovirus (Carney & Hirsch, 1981) , dengue virus (Halstead et al., 1977) , respiratory syncytial virus (Domurat et al., 1985) and human immunodeficiency virus (HIV) (Nicholson et al., 1986) .
Lymphocytic choriomeningitis virus (LCMV), like other arenaviruses, causes relatively little overt c.p.e, in infected cells and is thought to induce disease through interference with specialized host cell functions or through immunopathological host responses to viral antigens (Oldstone, 1989) . However, some adverse effects of arenavirus infections may arise by release of cytokines and other soluble mediators from infected cells, either directly or in the course of the antiviral immune response Frei et al., 1989) . Since cells of the monocyte/macrophage lineage are both targets and reservoirs for LCMV and other arenaviruses (Jacobs & Cole, 1976; Murphy & Walker, 1978; Peters et al., 1987;  "~ Present address: CDC/NCID/DVRV Special Pathogens Branch, 1600 Clifton Road, Atlanta, Georgia 30333, U.S.A. Ambrosio et al., 1990) , it would be of interest to understand the modulation of mediators subsequent to virus infection of these cells. Monocytes/macrophages secrete a variety of pleiotropic cytokines, including interleukin 1 (IL-1) (Krakauer & Oppenheim, 1992) , tumour necrosis factor alpha (TNF-~t) (Beutler & Cerami, 1986) and interleukin 6 (IL-6) (Van Snick, 1990) . All three cytokines are proinflammatory and have potent immuno-enhancing effects, which might contribute to the pathogenesis of arenaviral haemorrhagic fever in human and rodent hosts.
We undertook this study to establish an in vitro model of LCMV infection in a human monocytic cell line, THP-1. We also examined the direct effects of LCMV on the production of cytokines by these cells and the effect of LPS, a potent stimulant for macrophages, on LCMVinfected THP-1 cells.
THP-1, a human monocytic leukaemic cell line, was cultured as described previously in RPMI 1640 medium containing 10 % fetal calf serum (FCS) (Tsuchiya et al., 1980) . Cultures of THP-1 cells in 24-well plates with 1 x 10 ~ cells per ml were infected with LCM.ARM or LCM. WE for 1 h. After adsorption of virus, the culture medium was replaced and LPS or cytokines were added. Supernatants were collected at the indicated times for cytokine assays or virus assays. Cells were washed, spotted, acetone-fixed on slides and stained by 3.3 x l0 n 65 IL-6 (500 units/ml) 3.0 x 105 85 IFN-~ (120 units/ml) 7.5 x 104 5 * M.o.i. was 0"2 in this experiment. t Concentrations of antibodies used were as follows: anti-IL-l~ (10 units/ml), anti-IL-lfl (500 units/ml), anti-TNF-~ (50 units/ml), anti-IL-6 (0.2 ~tg/ml), anti-IFN-~ (3000 units/ml).
:~ Standard errors were within 5% of the mean. Results were representative of three experiments. * Experimental conditions were the same as described in Table 1. fluorescein-labelled, guinea-pig anti-LCMV. ARM antibody (Genovesi & Peters, 1987) . The extent of virusinfected cells was estimated by the number of immunofluorescent cells. In each experiment, duplicate samples were analysed and at least 100 cells were counted from three randomly selected fields. Viral titres were determined by a standard plaque assay as described (Genovesi & Peters, 1987) . Levels of interferon 0~ (IFN-00 and IFN-fl were quantified by measuring the reduction of c.p.e, on bovine kidney MDBK and human amnionic WISH cells infected with vesicular stomatitis virus (Rubinstein et al., 1981) . IL-lfl and TNF-~ were estimated by using an ELISA kit (Cistron).
Human recombinant IL-I~ (1.3 x 107 units/rag) and IL-lfl (5 x 107 units/rag) were kindly provided by the Biological Response Modifiers Program (National Cancer Institute, Frederick, Md., U.S.A.). Human recombinant IFN-0¢ (3xl0Sunits/mg), human recombinant IL-6 (2× 10Sunits/ml), anti-human IL-10¢ (500 units/ml), anti-human IL-lfl (15 000 units/ml) and anti-human IL-6 (7"51xg/ml) were obtained from Collaborative
Research. Anti-human IFN-~ (1.9 × 105 units/ml) was purchased from Interferon Science. Anti-human TNF-c~ (1000 units/ml) and human recombinant TNF-0~ (2 x 105 units/ml) were obtained from Boehringer Mannheim. Different doses of virus were used to determine whether THP-1 cells were permissive for LCM. WE or LCM. ARM. There was little variation in the number of immunofluorescence (IF)-positive cells with different m.o.i. (0"04 to 1) for either strain of LCMV (Fig. 1) . When LPS was added to THP-1 cells, there was a dramatic reduction in the number of infected cells (Fig.  1 ). This effect was observed for both viral strains at all three m.o.i.
As LPS can induce IL-1, TNF-~ and IL-6, we determined whether these cytokines could mediate the effect of LPS. Antibodies to human IL-1, TNF-0~, and IL-6 did not abolish the antiviral effect of LPS against LCMV. WE, as assessed by viral titre and the percentage of IF-positive THP-1 cells (Table 1) . Adding these cytokines to cells in the absence of LPS also did not change the establishment of viral infection.
To determine whether these cytokines had a specific effect on different LCMV strains, we examined the effects of IL-1, TNF-~ and IL-6 on LCMV.ARM. Table 2 shows that these cytokines had no antiviral activity. TNF-0~ is reported to have antiviral activity in some cells, and to synergize with IFN-y in its antiviral action (Wong & Goeddel, 1986) . However, with the cells and viruses tested here, TNF-0~ had no antiviral effect and there was no synergy with IFN-y (data not shown). The number of IF-positive cells varied between experiments (range of 80 to l0 %).The viral yield, however, was more consistent. This can be explained by the fact that viral antigens were measured by IF whereas whole virus particles were Monocytes/macrophages are capable of producing IFN-~, depending on the inducing agents used. We, therefore, investigated whether IFN-~ was involved in the action of LPS. Antibodies to IFN-~ failed to block the antiviral effect of LPS against LCMV (Tables 1 and  2 ). However, when IFN-~ was added alone to LCMVinfected cells, both viral titre and the percentage of infected cells were drastically reduced (Tables 1 and 2 ). This indicates that IFN-~ was capable of inducing an antiviral state in THP-1 cells.
As viruses are good inducers of interferons, we next studied the production of IFN-~ and -fl by THP-1 cells. Supernatants (days 1 to 5) from LCMV-infected cells in the presence or absence of LPS did not contain IFN-~ or -ft. The assay had detection limits of 2 units/ml of IFNand 3 units/ml of IFN-fl (data not shown). Table 3 shows that neither LCM. WE nor LCM. ARM induced IL-1-/? or TNF-~ production by these cells. THP-1 cells produced only IL-lfl and TNF-~ when LPS was the inducing agent. Adding LCMV to cells in the presence of LPS did not alter the levels of IL-l-fl or TNF-~ produced.
These data establish the protective effect of LPS and IFN-~ against LCMV in THP-1 cells. In kinetic studies, LPS was effective, even when added 1 day after exposing THP-1 cells to virus, which is similar to the protection achieved when LPS was added immediately upon infection. This suggests that LPS acts at a point after viral binding and penetration. LPS could act by altering cellular metabolism to decrease the efficiency of virus production. Therefore we explored the possibility of the action of LPS on the induction of RNase by means of 2'-5' oligoadenylate synthetase (Lengyel, 1982) . However, because we could not detect this enzyme in cells treated with LPS and virus, we cannot draw any conclusions about the involvement of 2'-5' oligoadenylate synthetaseassociated RNases in virus inhibition.
Our results on the antiviral activity of LPS are similar to those recently reported identifying an antiviral effect of LPS against HIV in infected human U937 monocytoid cells (Kornbluth et al., 1989) . However, in that study, a significant amount of IFN-~ was produced with HIVinfected U937 cells and accounted for some of the antiviral activity of LPS. Although macrophages are important producers of IFN-~ and -]/, the production of IFN is highly dependent on the type of inducers and the differentiation state of the macrophage; in some cases, a priming signal by other cytokines is required before LPS can induce IFN (Hayes et al., 1991) . Human IFNs are known to suppress the replication of HIV (Kornbluth et al., 1989) , herpes simplex (Mufioz & Carrasco, 1984) , dengue (Kurane & Ennis, 1987) and rubella (Van Der Logt et al., 1980) viruses in vitro. The molecular mechanisms responsible for the inhibition of virus replication differ considerably among virus types and host cells (Samuel, 1991) . IFNs induce the synthesis of interferon-regulated proteins that cause the inhibition of virus production. At present, we do not know whether LPS can directly or indirectly (through the production of cytokines) influence the synthesis of these proteins. Because the monocyte/macrophage represents a major target of LCMV and other viruses and serves as a reservoir for viral persistence, the fact that LPS reduced viral load has obvious importance. Further work is needed to characterize the mechanism activated by LPS in macrophages that is responsible for the inhibition of LCMV infection.
